Phase II Neoadjuvant Trial of Paclitaxel by 96-Hour Continuous Infusion (CIVI) in Combination With Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non–Small-Cell Lung Cancer

作者: O. S. Breathnach , V. Kasturi , F. Kaye , L. Herscher , M. S. Georgiadis

DOI: 10.1097/00000421-200206000-00013

关键词:

摘要: Sixteen patients with untreated locally advanced (n = 15) or recurrent 1) non–small-cell lung cancer (NSCLC) were enrolled in this study between July 1996 and March 1999. Eight had stage IIIA NSCLC, seven IIIB disease, one disease after prior resection of st

参考文章(22)
F Nathan, C Khater, N Haas, M Cornfield, B Giantonio, R Greenberg, L Gomella, S Litwin, E Ross, S Roethke, C McAleer, G R Hudes, Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. Journal of Clinical Oncology. ,vol. 15, pp. 3156- 3163 ,(1997) , 10.1200/JCO.1997.15.9.3156
M S Georgiadis, B S Schuler, J E Brown, L V Kieffer, S M Steinberg, W H Wilson, C H Takimoto, M J Kelley, B E Johnson, Paclitaxel by 96-hour continuous infusion in combination with cisplatin : A phase I trial in patients with advanced lung cancer Journal of Clinical Oncology. ,vol. 15, pp. 735- 743 ,(1997) , 10.1200/JCO.1997.15.2.735
A D Seidman, D Hochhauser, M Gollub, B Edelman, T J Yao, C A Hudis, P Francis, D Fennelly, T A Gilewski, M E Moynahan, V Currie, J Baselga, W Tong, M O'Donaghue, R Salvaggio, L Auguste, D Spriggs, L Norton, Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer. Journal of Clinical Oncology. ,vol. 14, pp. 1877- 1884 ,(1996) , 10.1200/JCO.1996.14.6.1877
B Jeremic, Y Shibamoto, L Acimovic, L Djuric, Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. Journal of Clinical Oncology. ,vol. 13, pp. 452- 458 ,(1995) , 10.1200/JCO.1995.13.2.452
P D Bonomi, D M Finkelstein, J C Ruckdeschel, R H Blum, M D Green, B Mason, R Hahn, D C Tormey, J Harris, R Comis, Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology. ,vol. 7, pp. 1602- 1613 ,(1989) , 10.1200/JCO.1989.7.11.1602
W H Wilson, B A Chabner, G Bryant, S Bates, A Fojo, J Regis, E S Jaffe, S M Steinberg, B R Goldspiel, B D Cheson, Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas. Journal of Clinical Oncology. ,vol. 13, pp. 381- 386 ,(1995) , 10.1200/JCO.1995.13.2.381
A Younes, J P Ayoub, F B Hagemeister, P McLaughlin, A Sarris, M A Rodriguez, F Swan, J E Romaguera, J Martin, F Cabanillas, No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule. Journal of Clinical Oncology. ,vol. 14, pp. 543- 548 ,(1996) , 10.1200/JCO.1996.14.2.543
Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara, Hideki Nishikawa, Yoshiki Takada, Shinzoh Kudoh, Nobuyuki Katagami, Yutaka Ariyoshi, Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 17, pp. 2692- 2692 ,(1999) , 10.1200/JCO.1999.17.9.2692
Carlos A. Perez, Thomas F. Pajak, Philip Rubin, Joseph R. Simpson, Mohammed Mohiuddin, Luther W. Brady, Ruheri Perez-Tamayo, Marvin Rotman, Long‐term observations of the patterns of failure in patients with unresectable non‐oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group Cancer. ,vol. 59, pp. 1874- 1881 ,(1987) , 10.1002/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z